Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients
dc.contributor.author | Scorilas, A. | en |
dc.contributor.author | Yotis, J. | en |
dc.contributor.author | Gouriotis, D. | en |
dc.contributor.author | Keramopoulos, A. | en |
dc.contributor.author | Ampela, K. | en |
dc.contributor.author | Trangas, T. | en |
dc.contributor.author | Talieri, M. | en |
dc.date.accessioned | 2015-11-24T16:35:02Z | |
dc.date.available | 2015-11-24T16:35:02Z | |
dc.identifier.issn | 0250-7005 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/7889 | |
dc.rights | Default Licence | - |
dc.subject | Breast Neoplasms/*diagnosis/pathology | en |
dc.subject | Cathepsin D/*analysis | en |
dc.subject | Cytosol/chemistry | en |
dc.subject | Female | en |
dc.subject | Gene Amplification | en |
dc.subject | Genes, myc | en |
dc.subject | Humans | en |
dc.subject | Immunoradiometric Assay | en |
dc.subject | Lymphatic Metastasis | en |
dc.subject | Menopause | en |
dc.subject | Prognosis | en |
dc.subject | Proto-Oncogene Proteins/*analysis | en |
dc.subject | Receptor, Epidermal | en |
dc.title | Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients | en |
heal.abstract | In breast cancer, axillary lymph node invasiveness is the major prognostic factor in predicting relapse and metastasis. Nevertheless, since 30% of node-negative tumours also relapse, it is necessary to develop other independent prognostic factors. Oncogene amplification and overexpression as well as the level of cathepsin-D have been proposed as additional prognostic factors. Recent studies suggest that the acidic lysosomal proteinase cath-D, present in all cells and known to be secreted in breast cancer cells, may be implicated in the process of tumour invasion and metastasis. We have compared the cytosolic cath-D level with the amplification and the overexpression of the oncogenes c-myc and c-erb-b-2 in 62 breast carcinomas (52 primary and 10 metastatic). Using a cut-off level of 60 pmol/mg protein, the status of cath-D showed a positive correlation with c-myc amplification (P = 0.01) or overexpression (P = 0.02). In contrast, no correlation was found between cath-D and c-erb-B-2 amplification or overexpression. Also, no correlation was found between cath-D and established prognostic factors such as node invasiveness, steroid receptors, grade and menopausal status. Nevertheless, a weak correlation was found between cath-D levels and tumour status (P = 0.05). In conclusion, in breast cancer, a high cytosolic cath-D concentration is more frequent in tumours with c-myc amplification and overexpression but is dissociated from c-erb-B-2 amplification or overexpression, suggesting that the determination of cath-D, as well as the latter two markers, will have an additional prognostic value. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/7903524 | - |
heal.journalName | Anticancer Res | en |
heal.journalType | peer reviewed | - |
heal.language | en | - |
heal.publicationDate | 1993 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών και Τεχνολογιών. Τμήμα Βιολογικών Εφαρμογών και Τεχνολογιών | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: